Schedule 13D ownership disclosure
INOZYME PHARMA INC
Security class unavailable · CUSIP: 45790W108
Event date: 2022-04-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-127820
- Form type
- SC 13D
- Filer
- Inozyme Pharma, Inc.
- CIK
- CIK 1693011
- Filed
- Apr 28, 2022
- Reporting period
- Apr 19, 2022
- Description
- Schedule 13D beneficial ownership